Instem Exhibiting at Genetic Toxicology Association Meeting, Newark, Delaware
Instem To Showcase Leading Genetic Toxicology Solutions
CONSHOHOCKEN, PA– April 19, 2018 - - Instem, a leading provider of IT solutions to the global life sciences market, is pleased to announce they will be showcasing their leading genetic toxicology solutions (originally developed by Perceptive Instruments and now part of the Instem solution portfolio) at the Genetic Toxicology Association (GTA) Annual Scientific meeting, taking place May 3rd – 4th on the campus of the University of Delaware, Newark, DE.
The meeting offers a comprehensive program focusing on important emerging issues in the field of genetic toxicology and optional workshops will take place on May 2nd preceding the start of this year’s annual meeting.
Visitors to Instem’s booth will learn how organizations across the globe are using Instem solutions to improve the integration between data acquisition, auditing and reporting for regulatory genetox assays. Solutions on display will include:
- Comet Assay IV - the market leading live video imaging system for fast, accurate and reproducible slide comet scoring
- Cyto Study Manager - Data acquisition, integration and reporting for genetic toxicology assays, including modules for the comet assay, micronucleus test and chromosome aberrations
- Sorcerer Colony Counter – instant, automatic plate counting for GLP laboratories
- Ames Study Manager – plate counting, data management and reporting for the Ames test
Booth visitors will also be able to learn more about the latest FDA SEND (Standard for Exchange of Nonclinical Data) status as it applies to Genetic Toxicology studies.
The Genetic Toxicology Association (GTA) is a tax-exempt educational and scientific organization that was founded in 1975 and incorporated in 1981 under the laws of the state of Delaware. Its primary purpose is to promote the development of the science of genetic toxicology and to foster the exchange and dissemination of information concerning the field.
Instem is a global provider of leading software solutions and services that are helping over 500 clients bring their life enhancing products to market faster. We enable clients in the life sciences to more efficiently collect, analyze, report and submit high quality regulatory data, while maintaining compliance for their products around the world.
Instem solutions are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making, leading to safer, more effective products.
Instem supports its global roster of clients through offices in the United States, United Kingdom, France, Japan, China and India.
Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600
Gary Mitchell (US HQ)